Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' GRISWOLD DE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 62 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Sarau, HM; Widdowson, KL; Palovich, MR; White, JR; Underwood, DC; Griswold, DE
      Interleukin-8 receptor (CXCR2) antagonists

      NEW DRUGS FOR ASTHMA, ALLERGY AND COPD
    2. Underwood, DC; Griswold, DE
      Inhibition of p38 MAP kinase

      NEW DRUGS FOR ASTHMA, ALLERGY AND COPD
    3. Myles, BS; Barnhill, GP; Hagiwara, T; Griswold, DE; Simpson, RL
      A synthesis of studies on the intellectual, academic, social/emotional andsensory characteristics of children and youth with Asperger syndrome

      EDUCATION AND TRAINING IN MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES
    4. Adams, JL; Boehm, JC; Gallagher, TF; Kassis, S; Webb, EF; Hall, R; Sorenson, M; Garigipati, R; Griswold, DE; Lee, JC
      Pyrimidinylimidazole inhibitors of p38: Cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activity

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    5. Underwood, DC; Osborn, RR; Bochnowicz, S; Webb, EF; Rieman, DJ; Lee, JC; Romanic, AM; Adams, JL; Hay, DWP; Griswold, DE
      SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung

      AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
    6. Lee, JC; Kumar, S; Griswold, DE; Underwood, DC; Votta, BJ; Adams, JL
      Inhibition of p38 MAP kinase as a therapeutic strategy

      IMMUNOPHARMACOLOGY
    7. Griswold, DE; Douglas, SA; Martin, LD; Davis, TG; Davis, L; Ao, ZH; Luttmann, MA; Pullen, M; Nambi, P; Hay, DWP; Ohlstein, EH
      Targeted disruption of the endothelin-B-receptor gene attenuates inflammatory nociception and cutaneous inflammation in mice

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    8. Sarau, HM; Griswold, DE; Bush, B; Potts, W; Sandhu, P; Lundberg, D; Foley, JJ; Schmidt, DB; Webb, EF; Martin, LD; Legos, JJ; Whitmore, RG; Barone, FC; Medhurst, AD; Luttmann, MA; Giardina, GAM; Hay, DWP
      Nonpeptide tachykinin receptor antagonists. II. Ppharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potentand selective NK-3 receptor antagonist

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    9. Underwood, DC; Osborn, RR; Kotzer, CJ; Adams, JL; Lee, JC; Webb, EF; Carpenter, DC; Bochnowicz, S; Thomas, HC; Hay, DWP; Griswold, DE
      SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    10. Davis, HM; Carpenter, DC; Stahl, JM; Zhang, WY; Hynicka, WP; Griswold, DE
      Human granulocyte CD11b expression as a pharmacodynamic biomarker of inflammation

      JOURNAL OF IMMUNOLOGICAL METHODS
    11. Kumar, S; McDonnell, PC; Lehr, R; Tierney, L; Tzimas, MN; Griswold, DE; Capper, EA; Tal-Singer, R; Wells, GI; Doyle, ML; Young, PR
      Identification and initial characterization of four novel members of the interleukin-1 family

      JOURNAL OF BIOLOGICAL CHEMISTRY
    12. Podolin, PL; Webb, EF; Reddy, M; Truneh, A; Griswold, DE
      Inhibition of contact sensitivity in human CD4(+) transgenic mice by humanCD4-specific monoclonal antibodies: CD4(+) T-cell depletion is not required

      IMMUNOLOGY
    13. Badger, AM; Griswold, DE; Kapadia, R; Blake, S; Swift, BA; Hoffman, SJ; Stroup, GB; Webb, E; Rieman, DJ; Gowen, M; Boehm, JC; Adams, JL; Lee, JC
      Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis

      ARTHRITIS AND RHEUMATISM
    14. Sarau, HM; Foley, JJ; Schmidt, DB; Martin, LD; Webb, EF; Tzimas, MN; Breton, JJ; Chabot-Fletcher, M; Underwood, DC; Hay, DWP; Kingsbury, WD; Chambers, PA; Pendrak, I; Jakas, DR; Sathe, GM; Van Horn, S; Daines, RA; Griswold, DE
      In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activity

      PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
    15. Griswold, DE; Douglas, SA; Martin, LD; Davis, TG; Davis, L; Ao, ZH; Luttmann, MA; Pullen, M; Nambi, P; Hay, DWP; Ohlstein, EH
      Endothelin B receptor modulates inflammatory pain and cutaneous inflammation

      MOLECULAR PHARMACOLOGY
    16. Badger, AM; Blake, SM; Dodds, RA; Griswold, DE; Swift, BA; Rieman, DJ; Stroup, GB; Hoffman, SJ; Gowen, M
      Idoxifene, a novel selective estrogen receptor modulator, is effective in a rat model of adjuvant-induced arthritis

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    17. BROOKS DP; ADAMS J; DEPALMA PD; WEBB EF; GRISWOLD DE; PALMER R
      THE SELECTIVE CYCLOOXYGENASE-2 (COX-2) INHIBITOR, CELECOXIB, BUT NOT 6MNA, AFFECTS RENAL HEMODYNAMIC AND RENAL-FUNCTION IN THE DOG

      Journal of investigative medicine
    18. ZURKOWSKI JK; KELLY PS; GRISWOLD DE
      DISCIPLINE AND IDEA 1997 - INSTITUTING A NEW BALANCE

      Intervention in school and clinic
    19. GRISWOLD DE; MARTIN LD; BADGER AM; BRETON J; CHABOTFLETCHER M
      EVALUATION OF THE CUTANEOUS ANTIINFLAMMATORY ACTIVITY OF AZASPIRANES

      Inflammation research
    20. Adams, JL; Boehm, JC; Kassis, S; Gorycki, PD; Webb, EF; Hall, R; Sorenson, M; Lee, JC; Ayrton, A; Griswold, DE; Gallagher, TF
      Pyrimidinylimidazole inhibitors of CSBP/P37 kinase demonstrating decreasedinhibition of hepatic cytochrome P450 enzymes

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    21. WINKLER JD; SUNG CM; CHABOTFLECHER M; GRISWOLD DE; MARSHALL LA; CHILTON FH; BONDINELL W; MAYER RJ
      BETA-LACTAMS SB-212047 AND SB-216754 ARE IRREVERSIBLE, TIME-DEPENDENTINHIBITORS OF COENZYME-A-INDEPENDENT TRANSACYLASE

      Molecular pharmacology
    22. GRISWOLD DE; WEBB EF; BADGER AM; GORYCKI PD; LEVANDOSKI PA; BARNETTE MA; GROUS M; CHRISTENSEN S; TORPHY TJ
      SE-207499 (ARIFLO), A 2ND-GENERATION PHOSPHODIESTERASE-4 INHIBITOR, REDUCES TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-4 PRODUCTION IN-VIVO

      The Journal of pharmacology and experimental therapeutics
    23. JACKSON JR; BOLOGNESE B; HILLEGASS L; KASSIS S; ADAMS J; GRISWOLD DE; WINKLER JD
      PHARMACOLOGICAL EFFECTS OF SB-220025, A SELECTIVE INHIBITOR OF P38 MITOGEN-ACTIVATED PROTEIN-KINASE, IN ANGIOGENESIS AND CHRONIC INFLAMMATORY DISEASE-MODELS

      The Journal of pharmacology and experimental therapeutics
    24. CHRISTENSEN SB; GUIDER A; FORSTER CJ; GLEASON JG; BENDER PE; KARPINSKI JM; DEWOLF WE; BARNETTE MS; UNDERWOOD DC; GRISWOLD DE; CIESLINSKI LB; BURMAN M; BOCHNOWICZ S; OSBORN RR; MANNING CD; GROUS M; HILLEGAS LM; BARTUS JO; RYAN MD; EGGLESTON DS; HALTIWANGER RC; TORPHY TJ
      1,4-CYCLOHEXANECARBOXYLATES - POTENT AND SELECTIVE INHIBITORS OF PHOSPHODIESTERASE-4 FOR THE TREATMENT OF ASTHMA

      Journal of medicinal chemistry
    25. WEBB EF; TZIMAS MN; NEWSHOLME SJ; GRISWOLD DE
      INTRALESIONAL CYTOKINES IN CHRONIC OXAZOLONE-INDUCED CONTACT SENSITIVITY SUGGEST ROLES FOR TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-4

      Journal of investigative dermatology
    26. GRISWOLD DE; WEBB EF
      CUTANEOUS CYTOKINE PRODUCTION FROM INITIAL OXAZOLONE EXPOSURE

      Journal of investigative dermatology
    27. WHITE JR; LEE JM; YOUNG PR; HERTZBERG RP; JUREWICZ AJ; CHAIKIN MA; WIDDOWSON K; FOLEY JJ; MARTIN LD; GRISWOLD DE; SARAU HM
      IDENTIFICATION OF A POTENT, SELECTIVE NONPEPTIDE CXCR2 ANTAGONIST THAT INHIBITS INTERLEUKIN-8-INDUCED NEUTROPHIL MIGRATION

      The Journal of biological chemistry
    28. SARAU HM; GRISWOLD DE; POTTS W; FOLEY JJ; SCHMIDT DB; WEBB EF; MARTIN LD; BRAWNER ME; ELSHOURBAGY NA; MEDHURST AD; GIARDINA GAM; HAY DWP
      NONPEPTIDE TACHYKININ RECEPTOR ANTAGONISTS .1. PHARMACOLOGICAL AND PHARMACOKINETIC CHARACTERIZATION OF SB-223412, A NOVEL, POTENT AND SELECTIVE NEUROKININ-3 RECEPTOR ANTAGONIST

      The Journal of pharmacology and experimental therapeutics
    29. MEDHURST AD; HAY DWP; PARSONS AA; MARTIN LD; GRISWOLD DE
      IN-VITRO AND IN-VIVO CHARACTERIZATION OF NK3 RECEPTORS IN THE RABBIT EYE BY USE OF SELECTIVE NONPEPTIDE NK3 RECEPTOR ANTAGONISTS

      British Journal of Pharmacology
    30. DAVIS HM; CARPENTER DC; GOODLAVAGE JM; HYNICKA WP; GRISWOLD DE
      DEVELOPMENT OF A WHOLE-BLOOD FLOW CYTOMETRIC METHOD USING LDS-751 TO EVALUATE LTB4-INDUCED CD11B EXPRESSION

      Blood
    31. KUMAR S; TZIMAS MN; GRISWOLD DE; YOUNG PR
      EXPRESSION OF ST2, AN INTERLEUKIN-1 RECEPTOR HOMOLOG, IS INDUCED BY PROINFLAMMATORY STIMULI

      Biochemical and biophysical research communications
    32. GRISWOLD DE; RUFFOLO RR; POSTE G; TORPHY TJ
      RE-CLASSIFICATION OF NSAIDS

      Trends in pharmacological sciences
    33. ALBRIGHTSON CR; DYTKO G; GRISWOLD DE
      CSBP P28 KINASE MAY BE INVOLVED IN THE SIGNAL-TRANSDUCTION PATHWAY FOR PGE2 PRODUCTION/

      Journal of the American Society of Nephrology
    34. GRISWOLD DE; TZIMAS MN
      DIFFERENTIAL EXPRESSION OF CD44 LIGAND MESSENGER-RNA IN UV-IRRADIATEDSKIN

      The FASEB journal
    35. GRISWOLD DE; ADAMS JL
      CONSTITUTIVE CYCLOOXYGENASE (COX-1) AND INDUCIBLE CYCLOOXYGENASE (COX-2) - RATIONALE FOR SELECTIVE-INHIBITION AND PROGRESS TO DATE

      Medicinal research reviews
    36. BADGER AM; BRADBEER JN; VOTTA B; LEE JC; ADAMS JL; GRISWOLD DE
      PHARMACOLOGICAL PROFILE OF SB-203580, A SELECTIVE INHIBITOR OF CYTOKINE SUPPRESSIVE BINDING PROTEIN P38 KINASE, IN ANIMAL-MODELS OF ARTHRITIS, BONE-RESORPTION, ENDOTOXIN-SHOCK AND IMMUNE FUNCTION/

      The Journal of pharmacology and experimental therapeutics
    37. ADAMS JL; GARIGIPATI RS; SORENSON M; SCHMIDT SJ; BRIAN WR; NEWTON JF; TYRRELL KA; GARVER E; YODIS LA; CHABOTFLETCHER M; TZIMAS M; WEBB EF; BRETON JJ; GRISWOLD DE
      BICYCLIC N-HYDROXYUREA INHIBITORS OF 5-LIPOXYGENASE - PHARMACODYNAMIC, PHARMACOKINETIC, AND IN-VITRO METABOLIC STUDIES CHARACTERIZING (2,3-DIHYDRO-6-(PHENYLMETHOXY)-3-BENZOFURANYL)UREA

      Journal of medicinal chemistry
    38. BOEHM JC; SMIETANA JM; SORENSON ME; GARIGIPATI RS; GALLAGHER TF; SHELDRAKE PL; BRADBEER J; BADGER AM; LAYDON JT; LEE JC; HILLEGASS LM; GRISWOLD DE; BRETON JJ; CHABOTFLETCHER MC; ADAMS JL
      1-SUBSTITUTED 4-ARYL-5-PYRIDINYLIMIDAZOLES - A NEW CLASS OF CYTOKINE SUPPRESSIVE DRUGS WITH LOW 5-LIPOXYGENASE AND CYCLOOXYGENASE INHIBITORY POTENCY

      Journal of medicinal chemistry
    39. DAINES RA; CHAMBERS PA; FOLEY JJ; GRISWOLD DE; KINGSBURY WD; MARTIN LD; SCHMIDT DB; SHAM KKC; SARAU HM
      ETHYL]-3-(2-PHENYLETHOXY)-2-PYRIDINYL]-2-PROPENOIC ACID - A HIGH-AFFINITY LEUKOTRIENE B-4 RECEPTOR ANTAGONIST WITH ORAL ANTIINFLAMMATORY ACTIVITY

      Journal of medicinal chemistry
    40. GRISWOLD DE; HILLEGAS LM; OLEARYBARTUS J; LEE JC; LAYDON JT; TORPHY TJ
      EVALUATION OF HUMAN CYTOKINE PRODUCTION AND EFFECTS OF PHARMACOLOGICAL AGENTS IN A HETEROLOGOUS SYSTEM IN-VIVO

      Journal of immunological methods
    41. BARONE FC; HILLEGASS LM; TZIMAS MN; SCHMIDT DB; FOLEY JJ; WHITE RF; PRICE WJ; FEUERSTEIN GZ; CLARK RK; GRISWOLD DE; SARAU HM
      TIME-RELATED CHANGES IN MYELOPEROXIDASE ACTIVITY AND LEUKOTRIENE B-4 RECEPTOR-BINDING REFLECT LEUKOCYTE INFLUX IN CEREBRAL FOCAL STROKE

      Molecular and chemical neuropathology
    42. GALLAGHER TF; FIERTHOMPSON SM; GARIGIPATI RS; SORENSON ME; SMIETANA JM; LEE D; BENDER PE; LEE JC; LAYDON JT; GRISWOLD DE; CHABOTFLETCHER MC; BRETON JJ; ADAMS JL
      2,4,5-TRIARYLIMIDAZOLE INHIBITORS OF IL-1 BIOSYNTHESIS

      Bioorganic & medicinal chemistry letters
    43. GRISWOLD DE; CHABOTFLETCHER M; WEBB EF; MARTIN L; HILLEGASS L
      ANTIINFLAMMATORY ACTIVITY OF TOPICAL AURANOFIN IN ARACHIDONIC ACID-INDUCED AND PHORBOL ESTER-INDUCED INFLAMMATION IN MICE

      Drug development research
    44. CHABOTFLETCHER MC; UNDERWOOD DC; BRETON JJ; ADAMS JL; KAGEYSOBOTKA A; GRISWOLD DE; MARSHALL LA; SARAU HM; WINKLER JD; HAY DWP
      PHARMACOLOGICAL CHARACTERIZATION OF SB-202235, A POTENT AND SELECTIVE5-LIPOXYGENASE INHIBITOR - EFFECTS IN MODELS OF ALLERGIC-ASTHMA

      The Journal of pharmacology and experimental therapeutics
    45. NEWSHOLME SJ; GRISWOLD DE; SCHWARTZ L
      CONJUNCTIVAL LEUKOCYTE INFILTRATION EVOKED BY LEUKOTRIENES - DIFFERING RESPONSES AMONG RODENT SPECIES

      Journal of lipid mediators and cell signalling
    46. REDDY MP; WEBB EF; CASSATT D; MALEY D; LEE JC; GRISWOLD DE; TRUNEH A
      PYRIDINYL IMIDAZOLES INHIBIT THE INFLAMMATORY PHASE OF DELAYED-TYPE HYPERSENSITIVITY REACTIONS WITHOUT AFFECTING T-DEPENDENT IMMUNE-RESPONSES

      International journal of immunopharmacology
    47. LEE JC; PRABHAKAR U; GRISWOLD DE; DUNNINGTON D; YOUNG PR; BADGER A
      LOW-MOLECULAR-WEIGHT TNF BIOSYNTHESIS INHIBITORS - STRATEGIES AND PROSPECTIVES

      Circulatory shock
    48. ALBRIGHTSON CR; SHORT B; DYTKO G; ZABKOPOTAPOVICH B; BRICKSON B; ADAMS JL; GRISWOLD DE
      SELECTIVE-INHIBITION OF 5-LIPOXYGENASE ATTENUATES GLOMERULONEPHRITIS IN THE RAT

      Kidney international
    49. MARSHALL LA; WINKLER JD; GRISWOLD DE; BOLOGNESE B; ROSHAK A; SUNG CM; WEBB EF; JACOBS R
      EFFECTS OF SCALARADIAL, A TYPE-II PHOSPHOLIPASE A(2) INHIBITOR, ON HUMAN NEUTROPHIL ARACHIDONIC-ACID MOBILIZATION AND LIPID MEDIATOR FORMATION

      The Journal of pharmacology and experimental therapeutics
    50. DAINES RA; CHAMBERS PA; EGGLESTON DS; FOLEY JJ; GRISWOLD DE; HALTIWANGER RC; JAKAS DR; KINGSBURY WD; MARTIN LD; PENDRAK I; SCHMIDT DB; TZIMAS MN; SARAU HM
      )OCTYL]OXY]-2-PYRIDINYL]METHYL]THIO]METHYL]BENZOIC ACID AND RELATED-COMPOUNDS - HIGH-AFFINITY LEUKOTRIENE B-4 RECEPTOR ANTAGONISTS

      Journal of medicinal chemistry
    51. CHABOTFLETCHER M; BRETON J; LEE J; YOUNG P; GRISWOLD DE
      INTERLEUKIN-8 PRODUCTION IS REGULATED BY PROTEIN-KINASE-C IN HUMAN KERATINOCYTES

      Journal of investigative dermatology
    52. HENSLEY P; MCDEVITT PJ; BROOKS I; TRILL JJ; FEILD JA; MCNULTY DE; CONNOR JR; GRISWOLD DE; KUMAR NV; KOPPLE KD; CARR SA; DALTON BJ; JOHANSON K
      THE SOLUBLE FORM OF E-SELECTIN IS AN ASYMMETRIC MONOMER - EXPRESSION,PURIFICATION, AND CHARACTERIZATION OF THE RECOMBINANT PROTEIN

      The Journal of biological chemistry
    53. MURTHY SN; MURTHY N; GRISWOLD DE; HILLEGAS LM; WEBB EF
      INHIBITION OF LEUKOTRIENE BIOSYNTHESIS, CYTOKINE PRODUCTION AND DISEASE SEVERITY IN DEXTRAN SULFATE-MEDIATED COLITIS IN THE MOUSE BY SK-AND-F 107649, A SELECTIVE 5-LIPOXYGENASE (5-LO) INHIBITOR

      Gastroenterology
    54. GRISWOLD DE; HILLEGASS LM; BRETON JJ; ESSER KM; ADAMS JL
      DIFFERENTIATION IN-VIVO OF CLASSICAL NONSTEROIDAL ANTIINFLAMMATORY DRUGS FROM CYTOKINE SUPPRESSIVE ANTIINFLAMMATORY DRUGS AND OTHER PHARMACOLOGICAL CLASSES USING MOUSE-TUMOR NECROSIS FACTOR-ALPHA PRODUCTION

      Drugs under experimental and clinical research
    55. GRISWOLD DE; WEBB EF; BRETON J; WHITE JR; MARSHALL PJ; TORPHY TJ
      EFFECT OF SELECTIVE PHOSPHODIESTERASE TYPE-IV INHIBITOR, ROLIPRAM, ONFLUID AND CELLULAR-PHASES OF INFLAMMATORY RESPONSE

      Inflammation
    56. GRISWOLD DE; HILLEGASS LM; WHITE JR
      PHARMACOLOGICAL EVALUATION OF LEUKOTRIENE BIOSYNTHESIS AND INFLAMMATION IN AN ADOPTIVE MODEL OF PERITONEAL ANAPHYLAXIS IN THE MOUSE

      Drug development research
    57. BADGER AM; SWIFT BA; WEBB EF; CLARK RK; BUGELSKI PJ; GRISWOLD DE
      BENEFICIAL-EFFECTS OF SK-AND-F-105685 IN RAT ADJUVANT ARTHRITIS - PROPHYLACTIC AND THERAPEUTIC EFFECTS ON DISEASE PARAMETER PROGRESSION

      International journal of immunopharmacology
    58. RABINOVICI R; BUGELSKI PJ; ESSER KM; HILLEGASS LM; GRISWOLD DE; VERNICK J; FEUERSTEIN G
      TUMOR-NECROSIS-FACTOR-ALPHA MEDIATES ENDOTOXIN-INDUCED LUNG INJURY INPLATELET-ACTIVATING FACTOR-PRIMED RATS

      The Journal of pharmacology and experimental therapeutics
    59. DAINES RA; CHAMBERS PA; PENDRAK I; JAKAS DR; SARAU HM; FOLEY JJ; SCHMIDT DB; GRISWOLD DE; MARTIN LD; TZIMAS MN; KINGSBURY WD
      CARBOXYETHENYL)-5-[[8-(4-METHOXYPHENYL)OCTY-1]OXY] -2-PYRIDINYL]METHYL]THIO]METHYL]BENZOIC ACID - A NOVEL HIGH-AFFINITY LEUKOTRIENE B-4 RECEPTOR ANTAGONIST (VOL 36, PG 2703, 1 993)

      Journal of medicinal chemistry
    60. DAINES RA; CHAMBERS PA; PENDRAK I; JAKAS DR; SARAU HM; FOLEY JJ; SCHMIDT DB; GRISWOLD DE; MARTIN LD; KINGSBURY WD
      OCTYL]OXY]-2-PYRIDINYL]-METHYL]THIO]METHYL]BENZOIC ACID - A NOVEL HIGH-AFFINITY LEUKOTRIENE-B(4) RECEPTOR ANTAGONIST

      Journal of medicinal chemistry
    61. MURTHY SN; COOPER HS; HILLEGAS LM; GRISWOLD DE
      ACUTE PHASE RESPONSE OF SERUM AMYLOID P (SAP) COMPONENT IN DEXTRAN SULFATE (DSS)-INDUCED MURINE COLITIS

      Gastroenterology
    62. SMITH EF; GRISWOLD DE; EGAN JW; HILLEGASS LM; SMITH RAG; HIBBS MJ; GAGNON RC
      REDUCTION OF MYOCARDIAL REPERFUSION INJURY WITH HUMAN SOLUBLE COMPLEMENT RECEPTOR TYPE-1 (BRL-55730)

      European journal of pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/10/20 alle ore 03:45:20